Today’s AI Top Pick: AMRC

8/25/2026 · Contrarian screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Measured weekly model accuracy · AMRC64%45 resolved forecasts · 90d window · verify →

Today's pick · ContrarianAMRCBUY NOW8.6 / 108/25/2026

Ameresco (AMRC) has the cleanest contrarian-bounce setup in the pool: a real drawdown (-19% over 14d, -28.4% YTD) that has stopped making fresh lows on the shorter timeframes, multi-timeframe forecasts all pointing higher, AND a genuine positive catalyst that reframes the story. The 4h chart is coiled at the extreme low of its range (pos_in_21bar_range 2.22%, dd -23.98%) with fc_short +43.28%, fc_mid +53.21%, fc_long +45.07%. The 1d bar has actually turned positive (recent_21bar +6.66%) with fc_short +7.36%, fc_mid +29.19%, fc_long +25.52%. The 1wk is still ugly (-20.57%) but forecasts recover into fc_long +41.14% — the classic pattern of near-term stabilization inside a still-broken weekly trend. The fundamentals underwrite this: PEG 0.3, fwdPe 12.31, salesYoY +8.89%, analyst recom 1.67, and a huge target upside of 107.4% (fundamental_score 6.5 — the highest of any name here with a positive news backdrop). Bullish_prob is 1.0 with near_term_bullish 0.8, and the fresh SeekingAlpha piece "$1.5 Billion AI Power Backlog Changes The Story" (Aug 23) is exactly the kind of catalyst that turns "cheap and hated" into "re-rate candidate." That headline arrived AFTER the drawdown, which is why the shorter timeframes are stabilizing while the weekly is still catching down. Why today, not later? Position in range is essentially at the floor (2.22% on 4h, 0% on 1wk) — you are literally buying at the low of the recent range, not chasing. If price waits for the weekly to base further, you give up the fc_short +43% 4h window. The AI-power-backlog narrative is fresh and un-priced given how thin the bounce has been so far. I passed on CLBT despite the highest composite score because the Aug 21 headline explicitly cites CEO shift AND guidance cuts, and its 1wk forecast is negative (fc_mid -15.64%, fc_long -13.94%) — that's a broken-trend profile, not exhausted selling. REZI was the strong runner-up (CEO bought 15k shares at $20.46 vs current $19.38 — an actual insider bid), but its 1wk fc_mid/long are negative (-15.37%, -20.43%), whereas AMRC's are cleanly up.

Entry zone

$20.50–$21.30 (accumulate near current $20.97; add on any dip toward $20.00 which was the recent 4h floor)

Stop loss

$18.40 (below the 4h 21-bar low; ~12% risk — a break there invalidates the exhausted-selling thesis)

First target

$24.50–$25.00 (fc_mid 1d +29% ≈ $27; take partial at first meaningful resistance ~$25, gap fill)

Longer target

$29.50–$32.00 (aligns with fc_mid 4h +53% = ~$32 and fc_long 1wk +41% = ~$29.50; analyst target implies $43 at +107% upside as a stretch case)

Risks

Debt/Equity 1.63 is elevated — a rate re-acceleration or credit tightening hurts leveraged clean-energy names disproportionately
Short float 14% could squeeze up, but also means downside momentum can be violent if the $1.5B AI-backlog narrative gets challenged
GAAP profitMargin only 1.4% and PE 40 — the story depends on forward earnings ramp; any project-timing slip resets the multiple
1wk fc_short is -9.06%, so a further weekly leg down toward $18–19 before the bounce is a real scenario — hence the stop
"3 Industrials Stocks We Think Twice About" (Aug 24, StockStory) is mild but shows sell-side skepticism still active

Honorable mentions

REZICEO Thomas Surran bought 15,000 shares at $20.46 on Aug 24 vs. current $19.38 — you're buying below the insider bid. 4h fc_short +86%, 1d fc_long +50.15%, PE 8.53, fwdPe 10.25, ROE 15.2, position at literal floor (0% on 4h and 1wk). Only reason it's #2: 1wk fc_mid/long are -15.37%/-20.43%, so weekly trend is still contested.

EYECleanest multi-TF alignment (1h/4h/1d all bullish) with near_term_bullish 1.0. National Vision RAISED outlook (Aug 14), UBS reiterated Buy. fund_score 5.5, PEG 0.66, fwdPe 15.11. Held back only by a smaller drawdown (-17%) — less contrarian juice than AMRC/REZI.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	AMRC	BUY NOW	8.6	Bottom of 4h range, all-timeframe forecast lift, $1.5B AI-power backlog catalyst, PEG 0.3, target upside +107%.
2	REZI	BUY NOW	8.2	CEO bought 15k shares at $20.46 vs current $19.38; 4h fc_short +86%, PE 8.53, sitting at range floor.
3	EYE	BUY NOW	7.6	Full 1h/4h/1d bullish stack, raised guidance, PEG 0.66, but drawdown only -17% so smaller bounce edge.
4	IPGP	BUY PULLBACK	6.8	1d fc_mid +44%, RSI 31, debtEq 0.01, but PE 109 and no fresh catalyst; wait for retest of $70.
5	TSSI	BUY PULLBACK	6.3	ROE 32, PE 16.5, 1d fc_mid +73%, but 1wk fc_long -32.7% is a warning — trade small.
6	GRML	BUY PULLBACK	6.0	Landmark S-K 1300 resource estimate valuing project at $2.05B (Aug 24–25) is a huge catalyst but micro-cap and 1wk fc_short still -6%.
7	KAITO-USD	BUY PULLBACK	5.7	4h fc_long +142%, 1d fc_mid +40%, but 32.6M token unlock headline is an active overhang.
8	BICO-USD	BUY PULLBACK	5.4	-49.7% drawdown with bullish_prob 1 and +59% expected return — pure signal trade, no news to lean on.
9	DCGO	BUY PULLBACK	5.1	Record Q2 volumes and 1wk fc_long +623% are dramatic, but micro-cap with profitMargin -65% — speculative.
10	SNAL	BUY PULLBACK	5.0	Gamescom 2026 lineup with AAA title is a real catalyst; 4h fc_long +29% but 1d fc_long -73% is a red flag.
11	TGEN	WAIT	4.9	Data-center-momentum narrative and 1d fc_mid +62%, but 1wk fc_long -46% and Kolon TissueGene Phase 3 fail headline is a landmine (name confusion risk).
12	HFT-USD	WAIT	4.6	Crypto contrarian, expected return +36% but no timeframe detail to confirm exhaustion.
13	AVAV	WAIT	4.4	1d fc_mid +59%, but Aug 24 headlines flag $100M investment (dilution) and broad down day — momentum is against it.
14	CLBT	AVOID	4.2	Highest raw score, but Aug 21 GUIDANCE CUT plus 1wk fc_mid/long negative = broken trend, not exhausted selling.
15	AEON	WAIT	3.9	RSI 22 oversold and Buy reiterated, but HC Wainwright LOWERED PT to $1.20 and 1d fc_short -12%.
16	LTRN	WAIT	3.6	1d fc_long +80%, RSI 26.5, but ROE -400% and no catalyst — pure lottery ticket.
17	INTZ	WAIT	3.4	targetUpsidePct 1432% is meaningless; operMargin -191%, cash burn risk overwhelms signal.
18	IDN	WAIT	3.3	Profitable (PE 18.9, ROE 15.5) but fwdPe 144.5 and epsNextY -69% shows earnings falling off a cliff.
19	EVGN	AVOID	3.1	profitMargin -694%, salesYoY -80.6% — the drop is fundamental, not sentiment.
20	GITS	AVOID	3.0	Multi-TF forecast +20–40% but operMargin -116,965% and $5M market cap = untradeable.
21	EOSE	WAIT	2.9	Short float 32.4% could squeeze, but profitMargin -331% and recom 2.27 — no analyst support.
22	MIST	AVOID	2.7	profitMargin -3586%, PS 55 — priced for a binary clinical outcome, not a bounce trade.
23	RGNX	AVOID	2.6	debtEq 3.49, profitMargin -113%, and expected return only +28% — worst risk/reward in the pool.
24	AZIO	AVOID	2.5	Up 231% YTD then dumped; targetUpsidePct -41%, ROE -5,847% — this is a pump aftermath, not a dip.
25	MYPS	AVOID	2.4	targetUpsidePct 0%, recom 3, salesYoY -13% — no analyst thinks it's cheap here.
26	ONMD	AVOID	2.2	operMargin -696%, PS 24 — fundamentals broken beyond any bounce thesis.
27	TURB	AVOID	2.1	debtEq 4.36 in a $12M micro-cap; illiquid and no analyst target.
28	CISO	AVOID	2.0	targetUpsidePct 7,042% is a stale/broken data point; profitMargin -15% and no coverage.
29	SKYQ	AVOID	1.8	salesYoY -92%, profitMargin -806%, fund_score -3.75 — the business is disappearing.
30	LAB	AVOID	1.6	salesYoY -45%, recom 3.0, epsNextY -60% — every fundamental line is worsening.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord